|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Interest expense and amortization of debt discount on Term Loans (related party) | |||||
| Stock-based compensation for services | |||||
| Amortization of prepaid insurance | |||||
| Stock-based compensation | |||||
| Change in fair value of convertible notes payable (related party) | |||||
| Change in fair value of warrant liability (related party) | |||||
| Change in fair value of private warrant liability | |||||
| Change in fair value of publicly traded warrant liability | |||||
| Change in fair value of forward purchase agreement warrant liability | |||||
| Change in fair value of forward purchase agreement put option liability | |||||
| Change in fair value of forward purchase agreement warrant liability due to modification | |||||
| Change in fair value of forward purchase agreement warrant liability due to extension | |||||
| Net change in operating lease right-of-use assets and liability (related party) | |||||
| Change in inventory reserve | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Other receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Operating lease liabilities (related party) | |||||
| Operating lease liability (related party) | |||||
| Accrued expenses | |||||
| Product warranty liability | |||||
| Other liability | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from the issuance of convertible notes payable (related party) | |||||
| Proceeds from the issuance of stock | |||||
| Payments on insurance financing loans | |||||
| Proceeds from the issuance of Term Loans (related party) | |||||
| Dividends paid to stockholders of Series A Preferred Stock | |||||
| Proceeds from issuance of Common Stock under employee stock purchase plan | |||||
| Payment made for extinguishment of Term Loans (related party) | |||||
| Proceeds from the issuance of Class A Common Stock from ATM offering | |||||
| Proceeds from the PIPE Transaction, the forward purchase agreement, and the Business Combination, net of transaction costs | |||||
| Proceeds from issuance of Class A Common Stock under employee stock purchase plan | |||||
| Proceeds from exercise of forward purchase agreement warrants | |||||
| Proceeds from the sale of Common Stock associated with forward purchase agreement, net of transaction costs | |||||
| Proceeds from the issuance of Class A Common Stock and Investor Warrants from registered direct offering | |||||
| Offering costs from the issuance of Class A Common Stock and Investor Warrants from registered direct offering | |||||
| Deferred offering costs | |||||
| Proceeds from the issuance of Class A Common Stock associated with forward purchase agreement, net of transaction costs | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net (decrease) increase in cash | |||||
| Cash, beginning of year | |||||
| Cash, end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Deemed capital contribution from related party | |||||
| Non-cash investing and financing activities: | |||||
| Accrued and unpaid dividends on Series A Preferred Stock | |||||
| Financing of prepaid insurance | |||||
| Deemed capital contribution from related party | |||||
| SPAC excise tax liability recognized upon the Business Combination | |||||
| Convertible debt exchanged for equity | |||||
| Series A Preferred Shares issued to PIPE investor in connection with the Merger | |||||
| Issuance of Term Loan Warrants (related party) | |||||
| Accrued interest capitalized into term loans payable (related party) | |||||
| Modification of forward purchase agreement warrant | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
| Extinguishment of excess warrant liability upon exercise of forward purchase agreement warrant | |||||
| Waiver of accrued dividends associated with Sponsor Support Agreement | |||||
| Deemed dividend on waiver of restriction on Class A Common Stock | |||||
| Induced conversion of Series A Preferred Stock to Common Stock | |||||
| Induced conversion of Series A Preferred Stock to Class A Common Stock | |||||
| Bridge note exchanged for equity | |||||
| Series A Preferred Stock issued to PIPE investor in connection with the Merger | |||||
| Prepaid forward purchase agreement | |||||
| Extinguishment of excess warrant liability upon exercise of warrants associated with the forward purchase agreement | |||||
| Modification of forward purchase agreement warrant liability | |||||
| Property and equipment purchased on account | |||||
| Modification of Term Loan Warrants (related party) | |||||
| Deemed capital contribution associated with the extinguishment of Term Loans (related party) | |||||
| Issuance of Placement Agent Warrants | |||||
Loading...